Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Phase IV Comparison Trial for 2% Chlorhexidine Skin Asepsis +70% Alcohol Versus Aqueous Chlorhexidine (2%) for the Prevention of Catheter-related Bacteremia in Critical Patients: Preliminary Study

NCT03489512 is registered in ClinicalTrials.gov with Instituto de Investigacion Sanitaria La Fe as lead sponsor.

NCT NCT03489512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03489512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Phase IV Comparison Trial for 2% Chlorhexidine Skin Asepsis +70% Alcohol Versus Aqueous Chlorhexidine (2%) for the Prevention of Catheter-related Bacteremia in Critical Patients: Preliminary Study
Lead sponsor
Instituto de Investigacion Sanitaria La Fe
Phase
Phase 4
Overall status
Withdrawn
Start date
October 1, 2019
Completion date
April 1, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

central venous catheter related bacteremia, sepsis affecting skin